http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I646965-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-07 |
| filingDate | 2016-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bfd1b6d093b810d6f2e0996564fa1e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_930ea4bf61457e8dee5fbf397d373b25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_062f4cf1c8488759e980e6a32ee65fcd |
| publicationDate | 2019-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-I646965-B |
| titleOfInvention | Use of Pleurotus eryngii for the treatment or prevention of dementia and its symptoms |
| abstract | The present invention discloses a second use of Pleurotus eryngii, which refers to the use of Pleurotus eryngii for the preparation of a composition for treating and/or preventing a disease associated with an increase in phosphorylated tau-protein content and a disease associated with brain damage. Accordingly, by administering a composition containing an effective amount of Pleurotus eryngii to a body, especially an individual whose phosphorylated tau-protein content is too high or brain damage, the system can effectively improve the brain of the individual. Symptoms of impairment, memory, and learning ability decline. |
| priorityDate | 2016-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.